<DOC>
	<DOCNO>NCT01003223</DOCNO>
	<brief_summary>Cardiovascular disease major cause death hemodialysis ( HD ) patient associate widespread vascular calcification . There consensus chronic overload calcium phosphorus major factor vascular calcification . Hyperphosphatemia , deleterious dialysis patient , aggressively monitor treat . Phosphate binder - design bind dietary phosphate thus prevent absorption , ubiquitous dialysis patient population , calcium-based phosphate binder often first line therapy tolerate well patient low cost . Phosphate Kinetic Modeling ( PKM ) tool help physician manage hemodialysis patient 's phosphate level . Once subject consent participate study , subject 's dietary phosphate intake estimate appropriate dose phosphate binder calcium acetate ( PhosLo ) recommend accordingly . If necessary , Ca++ concentration dialysate change remove excess calcium absorb result increase PhosLo prescription control phosphorus.Ongoing recommendation regard oral phosphate binder dialysate calcium make use computer generate algorithm .</brief_summary>
	<brief_title>Phosphate Kinetic Modeling</brief_title>
	<detailed_description>PKM consist set validated computerized algorithm perform follow step : 1 . Calculate calcium ( Ca ) phosphorus ( P ) intake absorption individual patient function prescribe dose Vitamin D analogue , protein catabolic rate ( PCR ) dietary binder Ca intake . 2 . Calculate P removal dialyse P binder P Ca removal dialysis kinetic analysis total P Ca transport dialysis base dialyzer P Ca transport coefficient level dialysate Ca serum Ca P. 3 . Thus analysis intake , absorption removal program calculate net Ca P balance model patient . 4 . Calculate dose phosphate binder require reduce serum P normal patient hyperphosphatemia . 5 . Calculate dialysate Ca require achieve zero calcium balance complete dialysis cycle - interdialytic interval immediately succeed dialytic interval . 6 . The program also compute Phosphorus-Protein index ( PPI , total P remove divide PCR , mg/gm/day ) provide quantitative index compliance prescribe dietary P restriction and/or prescribe dose binder . If PPI exceed 18 , report indicate likely patient compliance respect prescribe diet and/or binder . It hop information valuable guide semiquantitative evaluation diet P binder intake patient difficult manage . Patients model monthly basis pre- post-dialytic Ca , P , PCR routine data readily available blood dialysate flow rate , fluid removal etc . A monthly report generate physician staff Norma Ofsthun , PhD contain analysis recommendation change therapy .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Hyperphosphatemia</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . Thrice weekly hemodialysis dialysate Ca++ concentration ( CdiCa ) 2.25 2.5 mEq/L 3 . Stable CdiCa either 2.25 2.5 mEq/L ≥ 4 week 4 . Dialysis vintage ≥ 6 month 5 . Current serum phosphorus ( `` month 1 '' ) &gt; 5.5 mg/dL average serum phosphorus month 1 3 &gt; 5.5 mg/dL average serum phosphorus month 1 6 &gt; 5.5 mg/dL 6 . Patients currently prescribe calcium acetate ( PhosLo ) monotherapy , sevelamer monotherapy , combination therapy PhosLo plus sevelamer phosphate bind 7 . Fresenius Optiflux F 160 , 180 200 dialyzer 1 . Parathyroidectomy 2. iPTH &lt; 50 pg/mL 3 . Dialysate potassium prescription 2 3 mmol/L Corrected serum Ca++ &lt; 7.5 mg/dL</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>phosphorus</keyword>
	<keyword>dialysis</keyword>
	<keyword>PhosLo</keyword>
	<keyword>CKD stage V</keyword>
</DOC>